Liver function test (LFT) data, available for a subset of patients, revealed elevated levels of SGOT-Aspartate Transaminase (AST) in 71.54% (n = 538) and SGPT-Alanine Transaminase (ALT) in 55.44% (n = 438) of dengue patients, markers often associated with severe dengue. The gene discussed is GPT; the disease is dengue disease.